Skip to main content
. 2022 Aug 29;12(14):6273–6290. doi: 10.7150/thno.76854

Figure 2.

Figure 2

Miscellaneous immune cells inside tumors. The tumor-associated immune cells may possess tumor-antagonizing or tumor-promoting capacities. The homogeneous immune cells are able to change their state due to different tumor ecosystem or different stages of tumorigenesis. For instance, macrophages can shift from a hostile to a friendly status after immunotherapy. Elevating the amount of tumor-antagonizing immune cells opens a broad window for tumor treatment.